Dr. Slivnick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Hollister Dr
Ste 112
Libertyville, IL 60048Phone+1 847-367-6781Fax+1 847-367-7384
Education & Training
- Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1983 - 1986
- University of Illinois College of MedicineClass of 1983
Certifications & Licensure
- IL State Medical License 1985 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 6 citationsPoor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine).Harvey D. Preisler, Parameswaran Venugopal, Stephanie A. Gregory, Wei-Tong Hsu, Jerome Loew
Leukemia Research. 2000-08-01 - 172 citationsCD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells.Thomas M. Ellis, Patricia E. Simms, D J Slivnick, Hans-Martin Jäck, R I Fisher
Journal of Immunology. 1993-09-01 - 63 citationsThe impact of Hodgkin's disease on the immune system.D J Slivnick, T M Ellis, J F Nawrocki, Richard I. Fisher
Seminars in Oncology. 1990-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: